cephradine - Profile
✉ Email this page to a colleague
What are the generic sources for cephradine and what is the scope of freedom to operate?
Cephradine
is the generic ingredient in six branded drugs marketed by Glaxosmithkline, Barr, Ivax Sub Teva Pharms, Teva, Vitarine, Apothecon, Ersana, and Bristol Myers Squibb, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.Summary for cephradine
| US Patents: | 0 |
| Tradenames: | 6 |
| Applicants: | 8 |
| NDAs: | 15 |
US Patents and Regulatory Information for cephradine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | ANSPOR | cephradine | CAPSULE;ORAL | 061859-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | ANSPOR | cephradine | CAPSULE;ORAL | 061859-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Barr | CEPHRADINE | cephradine | CAPSULE;ORAL | 062850-001 | Apr 22, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Barr | CEPHRADINE | cephradine | CAPSULE;ORAL | 062851-001 | Apr 22, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
